Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
Add more filters










Publication year range
1.
Am J Trop Med Hyg ; 65(5): 450-5, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11716097

ABSTRACT

In vitro drug susceptibility profiles were assessed in 75 Plasmodium falciparum isolates from 4 sites in Myanmar. Except at Mawlamyine, the site closest to the Thai border, prevalence and degree of resistance to mefloquine were lower among the Myanmar isolates as compared with those from Thailand. Geometric mean concentration that inhibits 50% (IC50) and 90% (IC90) of Mawlamyine isolates were 51 nM (95% confidence interval [CI], 40-65) and 124 nM (95% CI, 104-149), respectively. At the nearest Thai site, Maesod, known for high-level multidrug resistance, the corresponding values for mefloquine IC50 and IC90 were 92 nM (95% CI, 71-121) and 172 nM (95% CI, 140-211). Mefloquine susceptibility of P. falciparum in Myanmar, except for Mawlamyine, was consistent with clinical-parasitological efficacy in semi-immune people. High sensitivity to artemisinin compounds was observed in this geographical region. The data suggest that highly mefloquine-resistant P. falciparum is concentrated in a part of the Thai-Myanmar border region.


Subject(s)
Antimalarials/pharmacology , Artemisinins , Plasmodium falciparum/drug effects , Animals , Chloroquine/pharmacology , Drug Resistance , Mefloquine/pharmacology , Parasitic Sensitivity Tests , Sesquiterpenes/pharmacology
2.
Trans R Soc Trop Med Hyg ; 94(5): 537-44, 2000.
Article in English | MEDLINE | ID: mdl-11132385

ABSTRACT

Following a marked decline in the efficacy in vivo of mefloquine between 1990 and 1994, a combination of artesunate (4 mg/kg/d for 3 d) and mefloquine (25 mg/kg) has been used as first line treatment of uncomplicated falciparum malaria in camps for displaced persons located along the north-western border of Thailand. Antimalarial drug susceptibility of fresh isolates of Plasmodium falciparum from this population was evaluated using a radioisotope microdilution assay between 1995 and 1999. In total, 268 isolates were collected, of which 189 were from primary infections and 79 from recrudescent infections. The geometric mean 50% inhibitory concentration (IC50) values from primary infections were: dihydroartemisinin 1.2 ng/mL, artesunate 1.6 ng/mL, artemether 4.8 ng/mL, atovaquone 0.4 ng/mL, lumefantrine 32 ng/mL, chloroquine 149 ng/mL, quinine 354 ng/mL, mefloquine 27 ng/mL and halofantrine 4.1 ng/mL. A significant positive correlation was found between the susceptibility in vitro to artesunate and quinine (r = 0.43, P < 0.001), mefloquine (r = 0.46, P < 0.001), and halofantrine (r = 0.51, P < 0.001). These levels of resistance in vitro are among the highest reported and confirm continuing high level multidrug resistance in this area. Despite intensive use of the combination between 1995 and 1999 there has been a significant improvement in mefloquine sensitivity (P < 0.001) and artesunate sensitivity (P < 0.001). This supports observations in vivo that the combination of artesunate and mefloquine has reversed the previous decline in mefloquine sensitivity.


Subject(s)
Antimalarials/therapeutic use , Artemisinins , Malaria, Falciparum/drug therapy , Mefloquine/therapeutic use , Sesquiterpenes/therapeutic use , Adolescent , Adult , Aged , Animals , Artesunate , Child , Child, Preschool , Confounding Factors, Epidemiologic , Dose-Response Relationship, Drug , Drug Combinations , Female , Humans , Infant , Lethal Dose 50 , Malaria, Falciparum/epidemiology , Malaria, Falciparum/parasitology , Male , Microbial Sensitivity Tests , Middle Aged , Plasmodium falciparum/isolation & purification , Quality Control , Thailand/epidemiology
3.
Bull World Health Organ ; 77(5): 392-8, 1999.
Article in English | MEDLINE | ID: mdl-10361756

ABSTRACT

Reported are the in vitro susceptibilities of Plasmodium falciparum to artesunate, mefloquine, quinine and chloroquine of 86 isolates and to dihydroartemisinin of 45 isolates collected from areas of high resistance to mefloquine within Thailand near the borders with Myanmar and Cambodia, and from southern Thailand where P. falciparum is generally still sensitive to mefloquine. All the isolates were highly sensitive to artesunate, but the geometric mean IC50S were higher in isolates from the Thai-Myanmar and Thai-Cambodian borders than in those from southern Thailand. The IC50S for mefloquine and artesunate were strongly correlated (Pearson r = 0.605; n = 86; P < 0.00001). As expected, the in vitro sensitivities to dihydroartemisinin and artesunate were similar and strongly correlated (at IC50, Pearson r = 0.695; n = 45; P < 0.00002). The correlation between the activity of mefloquine and artesunate requires further investigation in order to determine the potential for development of cross-resistance in nature. Our results suggest that combination with mefloquine is not the ideal way of protecting the usefulness of artemisinin and its derivatives. A search for more suitable partner drugs to these compounds and careful regulation of their use are necessary in the interest of ensuring their long therapeutic life span.


Subject(s)
Antimalarials/pharmacology , Artemisinins , Drug Resistance , Malaria, Falciparum/drug therapy , Plasmodium falciparum/drug effects , Sesquiterpenes/pharmacology , Adolescent , Adult , Animals , Artesunate , Humans , Nonlinear Dynamics , Regression Analysis , Thailand
6.
Acta Trop ; 63(2-3): 151-8, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9088428

ABSTRACT

We performed in vitro drug susceptibility assays of ten Plasmodium falciparum isolates collected from Vict Nam in 1995. All isolates were found to be highly sensitive to artesunate, dihydro-artemisinin and artemisinin. They were also sensitive to quinine. All of them were resistant to chloroquine and mefloquine in vitro. This study provides the baseline estimates of in vitro susceptibility levels of the Vietnamese isolates to artermisinin and their derivatives because the data were collected soon after these drugs were introduced countrywide. It also describes some quantitative profiles of the in vitro response of other standard antimalarial drugs in Viet Nam, which is presently limited.


Subject(s)
Antimalarials/pharmacology , Artemisinins , Microbial Sensitivity Tests , Plasmodium falciparum/drug effects , Sesquiterpenes/pharmacology , Animals , Artesunate , Chloroquine/pharmacology , Mefloquine/pharmacology , Quinine/pharmacology , Vietnam
7.
Infect Immun ; 62(3): 855-62, 1994 Mar.
Article in English | MEDLINE | ID: mdl-8112855

ABSTRACT

Plasmodium falciparum malaria in humans is associated with an increase in the percentage and absolute number of gamma delta T cells in the peripheral blood. This increase begins during the acute infection phase and persists for at least 4 weeks during convalescence. In the present study, 25 to 30% of the gamma delta T cells expressed HLA-DR antigens in vivo and in some patients they proliferated in response to further stimulation by purified human interleukin 2 in vitro. However, there was no in vitro proliferative response to various malarial antigens, including a 75-kDa heat shock protein and a 72-kDa glucose-regulated protein of P. falciparum during the acute infection phase. Cytofluorographic studies showed that although an increase of V delta 1- gamma delta T cells was largely responsible for the expansion of the total number of gamma delta T cells, there was also a proportional increase in V delta 1+ cells. These results were confirmed with anchored PCR and by DNA sequencing to characterize at the molecular level the set of T-cell receptor (TCR) delta mRNAs expressed in the peripheral blood of two patients with high levels of gamma delta T cells. In each case, most of the TCR delta mRNA transcripts corresponded to nonproductively rearranged delta genes (unrearranged J delta or near J delta spliced to C delta). In those sequences which did represent productively rearranged genes, most of the transcripts originated from a V delta 2/J delta 1 joining, as in normal individuals. A minority of transcripts originated from a V delta 1/J delta 1 rearrangement, and one originated from a V alpha 4/J delta 1 rearrangement. Polyclonal activation of gamma delta T cells was inferred from the extensive junctional diversity seen in the delta mRNAs analyzed. Expansion of a heterogeneous set of both V delta 1(-)- and V delta 1(+)-bearing T cells suggests that the elevated levels of gamma delta T cells seen during acute P. falciparum malaria arose from immune responses to multiple distinct parasite antigens or unidentified host factors.


Subject(s)
Lymphocyte Activation , Malaria, Falciparum/immunology , Receptors, Antigen, T-Cell, gamma-delta/analysis , T-Lymphocytes/immunology , Adult , Amino Acid Sequence , Base Sequence , Humans , Interleukin-2/pharmacology , Molecular Sequence Data , Receptors, Antigen, T-Cell, gamma-delta/genetics
9.
Am J Trop Med Hyg ; 47(1): 112-6, 1992 Jul.
Article in English | MEDLINE | ID: mdl-1636877

ABSTRACT

Mefloquine was introduced into Thailand in 1985 for the treatment of Plasmodium falciparum infection. Recently, clinical failure of mefloquine was observed in southeastern Thailand, where an epidemic of falciparum malaria occurred. Beginning in 1984 and continuing until 1989, in vitro monitoring of P. falciparum isolates from Borai, a border district in the southeastern part of the country, showed a progressive decrease in mefloquine sensitivity until 1989; in 1990, the degree and prevalence of resistance accelerated. A similar pattern of resistance was observed for halofantrine, an antimalarial drug not yet commercially available in Thailand. In vitro sensitivity patterns of mefloquine and halofantrine elsewhere in the country remained relatively unchanged. These observations suggest a serious deterioration in available drugs for the treatment of falciparum malaria in southeastern Thailand that is predicted to spread throughout the country and Southeast Asia.


Subject(s)
Antimalarials/pharmacology , Malaria, Falciparum/parasitology , Mefloquine/pharmacology , Phenanthrenes/pharmacology , Plasmodium falciparum/drug effects , Animals , Antimalarials/therapeutic use , Drug Resistance , Humans , Malaria, Falciparum/drug therapy , Mefloquine/therapeutic use , Phenanthrenes/therapeutic use , Regression Analysis , Thailand
10.
Am J Trop Med Hyg ; 38(1): 19-23, 1988 Jan.
Article in English | MEDLINE | ID: mdl-3277459

ABSTRACT

An in vitro assay system has been developed to evaluate the susceptibility of field isolates of Plasmodium falciparum to standard and new antimalarials. The assay used drugs which were serially diluted in the field and determined effective drug concentrations by quantitating schizont maturation after a variable incubation period. Based on the ID50 values, a series of isolates from Yala in southern Thailand were shown to be resistant to chloroquine (187 nM) but only moderately resistant to amodiaquine (23.7 nM), a structurally related 4-aminoquinoline. Five aminocarbinols were evaluated. The parasites were resistant to quinine (219 nM), but comparatively much more susceptible to mefloquine (9.04 nM), halofantrine (1.23 nM), and enpiroline (6.23 nM). The isolates were also relatively sensitive to WR 194,965 (9.04 nM). Two dihydrofolate reductase inhibitors (WR 99,210 and pyrimethamine) were tested. The isolates were comparatively sensitive to a dihydrotriazine, WR 99,210 (2.85 nM). The in vitro values for pyrimethamine (1,870 nM) were higher than the values for the other drugs tested, but were less than values from other regions of Thailand. As compared to a survey conducted in this region four years previously, values for chloroquine, pyrimethamine, amodiaquine, and mefloquine have remained relatively unchanged. However, there was a greater than 20-fold rise in the susceptibility values for quinine, suggesting the introduction of quinine-resistant isolates from eastern Thailand into southern Thailand during this period.


Subject(s)
Antimalarials/pharmacology , Plasmodium falciparum/drug effects , Amodiaquine/pharmacology , Animals , Butylated Hydroxytoluene/analogs & derivatives , Butylated Hydroxytoluene/pharmacology , Chloroquine/pharmacology , Humans , Mefloquine , Parasitology/methods , Phenanthrenes/pharmacology , Pyridines/pharmacology , Pyrimethamine/pharmacology , Quinine/pharmacology , Quinolines/pharmacology , Thailand , Triazines/pharmacology
11.
Am J Trop Med Hyg ; 38(1): 24-9, 1988 Jan.
Article in English | MEDLINE | ID: mdl-3277460

ABSTRACT

Pyronaridine, a 9-substituted 1-aza-acridine, was assayed for in vitro activity against clinical and field isolates as well as characterized clones of Plasmodium falciparum. The in vitro antimalarial activity of pyronaridine was compared to activities of standard antimalarials against multidrug-resistant isolates of P. falciparum from eastern and northern Thailand using an assay based on the inhibition of schizont maturation. Isolates from eastern Thailand (n = 30) were susceptible to pyronaridine (IC50 8.40 nM), mefloquine (IC50 6.97 nM), and amodiaquine (IC50 12.7 nM) and resistant to chloroquine (IC50 361 nM), quinine (IC50 388 nM), and pyrimethamine (IC50 11,800 nM). The isolates from northern Thailand (n = 7) showed no statistical difference in susceptibility to pyronaridine (IC50 10.1 nM), amodiaquine (IC50 7.29 nM), and mefloquine (IC50 5.48 nM); however, isolates were significantly more susceptible to chloroquine (IC50 167 nM), quinine (IC50 248 nM), and pyrimethamine (IC50 1,980 nM). These data suggest a lack of cross-resistance between pyronaridine and either chloroquine, quinine, or pyrimethamine. Using the same assay system the in vitro activity of pyronaridine was evaluated against isolates from treatment failures of mefloquine or enpiroline from eastern Thailand. The IC50 values for mefloquine against five recrudescent isolates were significantly higher (IC50 16.4 nM) than the field isolates collected from the same region (IC50 6.97 nM); however, there was no significant difference in the pyronaridine susceptibility between the isolates from the field study (IC50 8.89 nM) and the isolates from the treatment failures (IC50 8.40 nM). These observations suggest a lack of cross-resistance to mefloquine following treatment failure with either mefloquine or enpiroline.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Antimalarials/pharmacology , Naphthyridines/pharmacology , Plasmodium falciparum/drug effects , Amodiaquine/pharmacology , Animals , Chemical Phenomena , Chemistry , Chloroquine/pharmacology , Drug Resistance , Humans , Mefloquine , Pyrimethamine/pharmacology , Quinine/pharmacology , Quinolines/pharmacology , Thailand
12.
Article in English | MEDLINE | ID: mdl-3329409

ABSTRACT

The in vitro susceptibility of twenty isolates of Plasmodium falciparum from Tha Song Yang, Tak province, Thailand were determined. The isolates were resistant to chloroquine (IC50 = 220 nM; MIC = 762 nM), quinine (IC50 = 252 nM; MIC = 1010 nM), and pyrimethamine (IC50 = 16400 nM; MIC = 43100 nM) but generally sensitive to mefloquine (IC50 = 6.90 nM; MIC = 20.9 nM) and halofantrine (IC50 = 8.73 nM; MIC = 2.71 nM). Two isolates were identified which appeared resistant to mefloquine (IC50 = 23.1 nM; MIC = 56.6 nM). These isolates may represent an extension of a population of parasites from eastern Thailand.


Subject(s)
Antimalarials/pharmacology , Malaria/parasitology , Plasmodium falciparum/drug effects , Quinolines/pharmacology , Animals , Antimalarials/therapeutic use , Drug Resistance , Humans , Malaria/drug therapy , Mefloquine , Quinolines/therapeutic use , Thailand
13.
Trans R Soc Trop Med Hyg ; 80(1): 66-8, 1986.
Article in English | MEDLINE | ID: mdl-3523866

ABSTRACT

The in vitro susceptibility of five field isolates of Plasmodium falciparum from the region of the Thai-Kampuchean border to pyrimethamine, sulphadoxine, and their combination, was determined using a microtitre test system and media deficient in p-aminobenzoic acid and folic acid. Two-fold serial dilutions of pyrimethamine ranging from concentrations of 8.0 to 0.125 microM and sulphadoxine ranging from 800 to 50 microM were evaluated for antimalarial activity. Viability was based on the maturation of the ring stages to normally-appearing schizonts. Tested singly the parasites had an average ID90 of 3.82 microM for pyrimethamine and greater than 800 microM for sulphadoxine. Analysis of the drugs interaction showed maximum potentiation at approximately 0.8 microM of pyrimethamine and 80 microM of sulphadoxine. These results suggest that resistance to Fansidar is due to the resistance to both components. Although there was a potentiating effect it was probably not sufficient enough for the drugs to be effective in vivo. This may, in part, explain the reduction in clinical cures with the sulphadoxine-pyrimethamine combination in eastern Thailand.


Subject(s)
Plasmodium falciparum/drug effects , Pyrimethamine/pharmacology , Sulfadoxine/pharmacology , Sulfanilamides/pharmacology , Drug Resistance, Microbial , Drug Synergism , Humans , Thailand
14.
Parasite Immunol ; 5(5): 431-40, 1983 Sep.
Article in English | MEDLINE | ID: mdl-6226919

ABSTRACT

Con A-pretreated mononuclear (MNC) cells from Thai adults with naturally acquired P. falciparum or P. vivax malaria were significantly less effective in suppressing the responsiveness of autologous or normal allogeneic responder cells to mitogenic lectins or allogenic stimulator cells than pretreated cells from healthy donors. Serial studies of three patients demonstrated that reduced suppressor cell activity was present early in malaria infection but returned to normal soon after treatment. These studies demonstrate that the loss of T cells previously observed in patients with malaria, in part may functionally represent a loss of suppressor T cells.


Subject(s)
Malaria/immunology , T-Lymphocytes, Regulatory/immunology , Adult , Concanavalin A/pharmacology , Humans , Lymphocyte Culture Test, Mixed , Malaria/blood , Malaria/drug therapy , Male , Phytohemagglutinins/pharmacology , Plasmodium falciparum , Plasmodium vivax , Thailand
15.
J Clin Microbiol ; 17(2): 296-304, 1983 Feb.
Article in English | MEDLINE | ID: mdl-6339549

ABSTRACT

To assess general cytotoxic effector cell capabilities by peripheral blood mononuclear cells from patients with active malaria infections, we examined antibody-dependent cellular cytotoxicity, spontaneous cell-mediated cytotoxicity, and lectin-induced cellular cytotoxicity by using human and chicken erythrocyte, Chang cell line, and K562 cell line targets. By using human erythrocyte and Change cell line targets, we found that Thai adults naturally infected with malaria had significantly impaired lectin-induced cellular cytotoxicity. In addition, spontaneous cell-mediated cytotoxicity was deficient with K562 but not with Chang cell line targets. Finally, no change in antibody-dependent cellular cytotoxicity was observed when chicken erythrocyte or Chang cell line targets were used. These observations, coupled with our previous observations of a physical loss of peripheral blood T cells, the presence of lymphocytotoxic serum antibodies, and defective T suppressor cell generation in patients with malaria, indicate that major alterations in the cellular immune system occur in patients with active malaria infections.


Subject(s)
Cytotoxicity, Immunologic , Lectins/pharmacology , Malaria/immunology , T-Lymphocytes/immunology , Adult , Animals , Antibody-Dependent Cell Cytotoxicity , Cell Line , Chickens , Cytotoxicity, Immunologic/drug effects , Erythrocytes/immunology , Humans , Killer Cells, Natural/immunology , Liver/immunology , Male , Plasmodium falciparum , Plasmodium vivax , Thailand
16.
Trans R Soc Trop Med Hyg ; 77(6): 767-70, 1983.
Article in English | MEDLINE | ID: mdl-6229909

ABSTRACT

The effect of mefloquine-HCL, a new 4-quinoline methanol anti-malarial compound, on in vitro blast transformation of human peripheral blood mononuclear cells (MNC) was studied. Mefloquine significantly suppressed lectin-induced blast transformation of MNC from healthy Thai adults but MNC responsiveness in the mixed leucocyte reaction (MLR) and cellular viability were not reduced by the concentrations of mefloquine studied. Both T and non-T MNC responsiveness was lower in cultures containing the drug than in normal control cultures. The addition of serum from individuals on mefloquine chemoprophylaxis caused no significant suppression in the blast transformation assays or the MLR but the data do not rule out any clinically significant in vivo suppressive effect by mefloquine on human cellular immune response.


Subject(s)
Antimalarials/therapeutic use , Lymphocytes/drug effects , Malaria/prevention & control , Quinolines/therapeutic use , Adult , Antigens, Surface/immunology , Humans , Immunity, Cellular/drug effects , Lectins/immunology , Lymphocyte Activation/drug effects , Lymphocyte Culture Test, Mixed , Lymphocytes/immunology , Mefloquine
SELECTION OF CITATIONS
SEARCH DETAIL
...